Phone: 1.510.856.5600|info@anthera.com

Investor Relations

We are focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs.

NASDAQ: ANTH
1.53
- 0.03 (-1.92%)
4:00 PM ET on Jul 25, 2017
Delayed at least 20 minutes.
Day High 1.58
Day Low 1.50
52-Week High 28.40
Volume 182,101
Print Friendly